Philip Arlen serves as Executive at Neogenix Oncology Inc, where they oversee executive responsibilities. Since joining the company, Philip Arlen has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 13, 2013 involved gifting 325,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 13, 2013 | NONE | $0 | Gift | 325,000 | $N/A | Discretionary |
Philip Arlen currently holds 1,331,161 shares of Neogenix Oncology Inc (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip Arlen has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Philip Arlen's most recent insider trade was on Feb 13, 2013, when they sold 325,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted